Cite
Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials.
MLA
Wu, Sijin, et al. “Association of Glucagon-like Peptide-1 Receptor Agonists with Cardiac Arrhythmias in Patients with Type 2 Diabetes or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Diabetology & Metabolic Syndrome, vol. 14, Dec. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13098-022-00970-2.
APA
Wu, S., Lu, W., Chen, Z., Dai, Y., Chen, K., & Zhang, S. (2022). Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome, 14, 1–12. https://doi.org/10.1186/s13098-022-00970-2
Chicago
Wu, Sijin, Wenzhao Lu, Zhongli Chen, Yan Dai, Keping Chen, and Shu Zhang. 2022. “Association of Glucagon-like Peptide-1 Receptor Agonists with Cardiac Arrhythmias in Patients with Type 2 Diabetes or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Diabetology & Metabolic Syndrome 14 (December): 1–12. doi:10.1186/s13098-022-00970-2.